Floatz logo

Omeprazole

KCNT1-Related Epilepsy

Actio Biosciences, Inc.Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the KCNT1-Related Epilepsy cohort.

Asset / SponsorPhaseRating
Abs-1230
Actio Biosciences, Inc.
Phase 2B

Same molecule, other indications

Omeprazole is also rated in:

morbid obesityDormant
BB
Indicative ·
70 / 100
View asset →
Helicobacter Pylori InfectionDormant
BB
Indicative ·
68 / 100
View asset →
primary mediastinal large B-cell lymphomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →